A review of the contribution of apo E genotypes to Alzheimer's disease risk and meta-analysis of apo E associations with other neuro-psychiatric disorders

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 7, Issue 3, 1997, Pages 267-275

  Rubinsztein, David C ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Apolipoprotein E; Neuropsychiatric disorders

Indexed keywords

EID: 0000174530     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630
2. Hanlon CS, Rubinsztein DC (1995) Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans. Atherosclerosis 112: 85-90
3. Weintraub MS, Eisenberg S, Breslow JL (1987) Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 80: 1571-1577
4. Heston LL (1992) Alzheimer's disease. In: King RA, Rotter JI, Motulsky AG (eds) The genetic basis of common diseases. Oxford University Press, Oxford, pp 792-800
5. Rubinsztein DC (1995) Apolipoprotein E; a review of its roles in lipoprotein metabolism, neuronal growth and repair and as a risk factor for Alzheimer's disease. Psychol Med 25: 223-229
6. Cruts M, Hendriks M, Van Broekhoven C (1996) The presenilin genes: a new family involved in Alzheimer disease pathology. Hum Molec Genet 5: 1449-1455
7. Pericak-Vance MA, Bebout JL, Gaskell PC, Yamaoka LA, Hung W-Y, Alberts MJ, Walker AP, Bartlett RJ, Haynes CA, Welsh KA, Earl NJ, Heyman A, Clark CM, Roses AD (1991) Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 48: 1034-1472
8. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E-high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90: 1977-1981
9. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
10. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1462-1472
11. Van Gool WA, Evenhuis HM, van Duijn CM, Dutch Study Group on Down's syndrome and ageing (1996) A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Ann Neurol 38: 225-230
12. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 7: 180-184
13. Rubinsztein DC, Hanlon CS, Irving RM, Goodburn S, Evans DG, Kellar-Wood H, Xuereb J, Bandmann O, Harding AE (1994) Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease. Mol Cell Probes 8: 519-525
14. Chartier-Harlin MC, Parfitt M, Legrain S, Perez-Tur J, Brousseau T, Evans A, Berr C, Vidai O, Roques P, Gourlet V, Fruchart J-C, Delacourte A, Rossor M, Amouyel P (1994) Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Molec Genet 3: 569-574
15. West HL, Rebeck GW, Hyman BT (1994) Frequency of the apolipoprotein epsilon 2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett 175: 46-48
16. Smith AD, Johnson C, Sim E, Jobst KA, Hindley N, King E (1994) Protective effect of apo epsilon 2 in Alzheimer's disease. Oxford Project to Investigate Memory and Ageing (OPTIMA) Lancet 344: 473-474.
17. Benjamin R, Leake A, McArthur FK, Ince PG, Candy JM, Edwardson JA, Morris CM, Bjertness E (1994) Protective effect of apo E epsilon 2 in Alzheimer's disease. Lancet 344: 473
18. Talbot C, Lendon C, Craddock NC, Shears S, Morris JC, Goate A (1994) Protection against Alzheimer's disease with apo E epsilon 2. Lancet 343: 1432
19. Roses AD, Devlin B, Conneally PM, Small GW, Saunders AM, Pritchard M, Locke PA, Haines JL, Pericak-Vance MA, Risch N (1995) Measuring the genetic contribution of APOE in late-onset Alzheimer disease. Am J Hum Genet 57 (Suppl): A202
20. Sobel E, Louhija J, Sulkava R, Davanipour Z, Kontula K, Miettinen H, Tikkanen M, Kainulainen K, Tivlis R (1995) Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology 45: 903-907
21. Asada T, Yamagata Z, Kinoshita T, Kariya T, Asaka A, Kahuma T (1996) Prevalence of dementia and distribution of apo E alleles in Japanese centenarians: an almost-complete survey in Yamanashi Prefecture, Japan. J Am Geriatr Soc 44: 151-155
22. Mayeux R, Stern Y, Ottman R, Tatemichi TK, Tang MX, Maestre G, Ngai C, Tycko B, Ginsberg H (1993) The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol 34: 752-754
23. Maestre G, Ottman R, Stern Y, Gurland B, Chun M, Tang MX, Shelanski M, Tycko B, Mayeux R (1995) Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 37: 254-259
24. Osuntokun BO, Sahota A, Ogunniyi AO, Gureje O, Baiyewu O, Adeyinka A, Oluwole SO, Komolafe O, Hall KS, Unverzagt FW, Hui SL, Yang M, Hendrie HC (1995) Lack of an association belween apolipoprotein E ε4 and Alzheimer's disease in elderly Nigerians. Ann Neurol 38: 463-465
25. Tang M-X, Maestre G, Tsai W-Y, Liu X-H, Feng L, Chung W-Y, Chun M, Schofield P, Tycko B, Mayeux R (1996) Relative risk of Alzheimer disease and age-at-onset distribution based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet 58: 574-584
26. Payami H, Zareparsi S, Montee KR, Sexton GJ, Kaye JA, Bird TD, Yu C-E, Wijsman EM, Heston LL, Litt M, Schellenberg GD (1996) Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 58: 803-811
27. Mayeux R, Ottman R, Maestre G, Ngai C, Tang M-X, Ginsberg H, Chun M, Tycko B, Shelanski M (1995) Synergistic effects of traumatic head injury and apolipoprotein-e4 in patients with Alzheimer's disease. Neurology 45: 555-557
28. Nicoll JA, Roberts GW, Graham DI (1996) Amyloid beta-protein, APOE genotype and head injury. Ann NY Acad Sci 777: 271-275
29. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST (1995) APOE*4-associated Alzheimer's disease risk is modified by αl-antichymotrypsin polymorphism. Nature Genet 10: 486-488
30. Haines JL, Pritchard ML, Saunders AM, Schildkraul JM, Growdon JH, Gaskell PC, Farrer LA, Auerbach SA, Gusella JF, Locke PA, Rosi BL, Yamaoka L, Small GW, Conneally PM, Roses AD, Pericak-Vance MA (1996) No genetic effect of α1-antichymotrypsin in Alzheimer's disease. Genomics 33: 53-56
31. Tysoe C, Galinsky D, Robinson D, Brayne C, Easlon DF, Hupperl FA, Dening T, Paykel ES, Rubinszlein DC (1996) Analysis of alpha-1 antichymotrypsin, presenilin-1, angiotensin converting-enzyme and methylenetelrahydrofolate reduclase loci as candidales for demenlia. Am J Med Genet (In Press)
32. Soininen HS, Riekkinen PJ, Sr, (1996) Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci 19: 224-228
33. Albert SM, Gurland B, Maestre G, Jacobs DM, Stern Y, Mayeux R (1995) APO E genotype influences functional status among elderly withoul demenlia. Am J Med Genet 60: 583-587
34. Van Broekhoven C, Backhovens H, Cruls M, Martin JJ, Crook R, Houlden H, Hardy J (1994) APO E genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett 169: 179-180
35. The French Alzheimer's Disease Collaborative Study Group (1996) Apolipoprotein E does not affect age at onset in patients with chromosome 14 encoded Alzheimer's disease. J Med Genet 33: 174-175
36. Sorbi S, Nacmias B, Forleo P, Piacentini S, Latorraca S, Amaducci L (1995) Epislatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Ann Neurol 38: 124-127
37. St George-Hyslop P, Crapper-McLachlan D, Tuda T, Rogaev E, Karlinsky H, Lippa CF, Pollen D (1994) Alzheimer's disease and possible gene interaction. Science 263: 537
38. Haan J, van Broekhoven C, van Duijn C, Voorhoeve E, Harskamp F, van Swieten JC, Maat-Schieman ML, Roos RAC, Bakker E (1994) The apolipoprotein E ε4 allele does not influence the clinical expression of the amyloid precursor gene codon 693 or 692 mutations. Ann Neurol 36: 434437
39. Van Duijn CM, de Knijff P, Wehnert A, De Voecht J, Bronzova JB, Havekas LM, Hofman A, Van Broekhoven C (1995) The apolipoprotein E ε2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 37: 605-610
40. Corder EH, Roses AD (1996) No increased risk of the apolipoprotein E ε2 allele with early-onset Alzheimer's disease. Ann Neurol 39: 414-415
41. Saunders AM, Schmader K, Breitner JCS, Benson MD, Brown WT, Goldfarb L, Goldgaber D, Manwaring MG, Szymanski MH, McKown N, Dole KC, Schmechel DE, Strittmatter WJ, Pericak-Vance MA, Roses AD (1993) Apolipoprotein Ee4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342: 710-711
42. Hardy J, Crook R, Perry R, Raghavan R, Roberts G (1994) ApoE genotype and Down's syndrome. Lancet 343: 979-980
43. Wisniewski T, Morelli L, Wegiel J, Levy E, Wisniewski HM, Frangione B (1995) The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome. Ann Neurol 37: 136-137
44. Mann DMA, Pickering-Brown SM, Siddons MA, Iwatsubo T, Ihara Y, Asami-Odaka A, Suzuki N (1995) The extent of amyloid deposition in brain in patients with Down's syndrome does not depend upon the apolipoprotein E genotype. Neurosci Lett 196: 105-108
45. Royston MC, Mann D, Pickering-Brown S, Owen F, Perry R, Raghavan R, Khin-Nu C, Tyrer S, Day K, Crook R, Hardy J, Roberts GW (1994) Apolipoprotein Ee2 allele promotes longevity and protects patients with Down's syndrome from dementia. Neuroreport 5: 2583-2585
46. St Clair D, Norrman J, Perry R, Yates C, Wilcock G, Brookes A (1994) Apolipoprotein E ε4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. Neurosci Lett 176: 45-46
47. Shimano H, Ishibashi S, Murase T, Gotohda T, Yamada N, Takaku F, Ohtomo E (1989) Plasma apolipoproteins in patients with multi-infact dementia. Atherosclerosis 79: 257-260
48. Menzel H-J, Kladetzky R-G, Assmann G (1983) Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 3: 310-315
49. Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1-21
50. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lessueur-Ginot L, Cohen D (1994) Genetic associations with human longevity at the APO E and ACE loci. Nature Genet 6: 29-32
51. De Andrade M, Thandi I, Brown S, Gotto A, Patsch W, Boerwinkle E (1994) Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. Am J Hum Genet 56: 1379-1390
52. Couderc R, Mahieux F, Bailleul S, Fenelon G, Mary R, Fermanian J (1993) Prevalence of Apolipoprotein E phenotypes in ischemic cerebrovascular disease: a case-control study. Stroke 24: 661-664
53. Farrer LA, Abraham CR, Volicer L, Forley EJ, Kowall NM, McKee AC, Wells JM (1995) Allele epsilon 4 of apolipoprotein E shows a dose effect on age of onset of Pick disease. Exp Neurol 136: 162-170
54. Amouyel P, Vidai O, Launay JM, Laplanche JL, French Research Group on Epidemiology of Human Spongiform Encephalopathies (1994) The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 344: 1315-1318
55. Mui S, Rebeck GW, McKenna-Yasek D, Hyman BT, Brown RH Jr (1995) Apolipoprotein E ε4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann Neurol 38: 460-463
56. Benjamin R, Leake A, Edwardson JA, McKeith IG, Ince PG, Perry RH, Morris CM (1994) Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet 343: 1565
57. Saunders AM, Hulette C, Welsh-Bohmer KA, Schmechel DE, Crain B, Burke JR, Alberts MJ, Strittmatter WJ, Breitner JCS, Rosenberg C, Scott SV, Gaskell PC Jr, Pericak-Vance MA, Roses AD (1996) Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 348: 90-93
58. Smith AD, Jobst KA, Johnson C, Joachim C, Nagy Z (1996) Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease. Lancet 348: 483-484
59. Kakulas BA, Wilton SD, Fabian VA, Jones TM (1996) Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease. Lancet 348: 483
60. Lippa CF, Smith TW, Saunders AM, Crook R, Pulaski-Salo D, Davies P, Hardy J, Roses AD, Dickson D (1995) Apolipoprotein E genotype and Lewy body disease. Neurology 45: 97-103
61. Betard C, Robitaille Y, Gee M, Tiberghien D, Larrivee, Roy P, Mortimer JA, Gauvreau D (1994) Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport 5: 1893-1896
62. Martinoli M-G, Trojanowski JQ, Schmidt ML, Arnold SE, Fujirawa TM, Lee VM-Y, Hurtig H, Julien J-P, Clark C (1995) Association of apolipoprotein ε4 allele and neuropathologic findings in patients with dementia. Acta Neuropathol 90: 239-243
63. Arai H, Higuchi S, Muramatsu T, Iwatsubo T, Sasaki H, Trojanowski JQ (1994) Apolipoprotein E gene in diffuse Lewy body disease with or without co-existing Alzheimer's disease. Lancet 344: 1307
64. Pickering-Brown SM, Mann DMA, Bourke JP, Roberts DA, Balderson D, Burns A, Byrne J, Owen F (1994) Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other β-amyloid-forming diseases. Lancet 343: 1155
65. Galasko D, Saitoh T, Xia Y, Thai LJ, Katzman R, Hill LR, Hansen L (1994) The apolipoprotein E allele ε4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 44: 1950-1951
66. Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM (1994) Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types; significance for etiological theories of Alzheimer's disease. Am J Pathol 145: 1472-1484
67. Frisoni GB, Calabresi L, Geroldi C, Bianchetti A, D'Aquarica ALD, Govoni S, Sirtori CR, Trabucchi M, Franceschini G (1994) Apolipoprotein Eε4 allele in Alzheimer's disease and vascular dementia. Dementia 5: 240-242
68. Noguchi S, Murakami K, Yamada N (1993) Apolipoprotein E genotype and Alzheimer's disease. Lancet 342: 737
69. Sakoda S, Kuriyama M, Osame M, Takahashi K, Yamono T (1994) Apolipoprotein Eε4. Neurology 44: 2420
70. Pirttila T, Lehtimaki T, Nikkari T, Frey H, Mattila K (1995) Apolipoprotein E E4 allele and risk of dementia. JAMA 273:375
71. Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J (1994) Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry 37: 1414-1416
72. Nagakawa Y, Kitamoto T, Furukawa H, Ogomori K, Tateishi J (1994) Apolipoprotein E in Creutzfeldt-Jakob disease. Lancet 345:68
73. Salvatore M, Seeber AC, Nacmias B, Petraroli R, D'Alessandro M, Sorbi S, Pocchiari M (1995) Apolipoprotein E in sporadic and familial Creutzfeldt-Jakob disease. Neuroscience Lett 199: 95-98
74. Zerr I, Helmhold M, Armstrong VW, Weber T (1995) Apolipoprotein E in Creutzfeldt-Jakob disease. Lancet 345: 68-69
75. Harrington CR, Roth M, Xuereb JH, McKenna PJ, Wischik CM (1995) Apolipoprotein E type ε4 allele frequency is increased in patients with schizophrenia. Neuroscience Lett 202: 101-104
76. Zhu S, Nothen MM, Uhlhaas S, Rietschel M, Korner J, Lanczik M, Fimmers R, Propping P (1996) Apolipoprotein E genotype distribution in schizophrenia. Psychiatric Genet 6: 75-79
77. Al-Chalabi A, Enayat ZE, Bakker MC, Sham PC, Ball DM, Shaw CE, Lloyd CM, Powell JF, Leigh PN (1996) Association of apolipoprotein E ε4 allele with bulbar-onset motor neuron disease. Lancet 347: 159-160
78. Smith RG, Haverkamp LJ. Case S, Appel V, Appel SH (1996) Apolipoprotein E ε4 in bulbar-onset motor neuron disease. Lancet 348: 335
79. Slooter AJC, Breteler MMB, Ott A, van Broekhoven C, van Duijn CM (1996) APO E genotyping in dfferential diagnosis of Alzheimer's disease. Lancet 348: 334